StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.42−0.85 (-16.13%)

Close on Nov 16, 2026Market cap $287.45MP/E –Yield –

Treace Medical Concepts profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Treace Medical Concepts's profit margin for the twelve months ending Jun 30, 2026 was -29.0%. For fiscal 2025 it was -27.7%, against -26.6% the year before. The highest annual figure on record is -6.4% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-27.7%−1.1
FY2024Dec 31, 2024-26.6%−0.2
FY2023Dec 31, 2023-26.5%+3.7
FY2022Dec 31, 2022-30.2%−8.4
FY2021Dec 31, 2021-21.8%−15.4
FY2020Dec 31, 2020-6.4%+4.4
FY2019Dec 31, 2019-10.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-35.0%+1.7
Q1 FY2026Mar 31, 2026-38.1%−7.8
Q4 FY2025Dec 31, 2025-15.0%−14.3
Q3 FY2025Sep 30, 2025-32.4%+1.6
Q2 FY2025Jun 30, 2025-36.7%+11.0
Q1 FY2025Mar 31, 2025-30.3%+6.3
Q4 FY2024Dec 31, 2024-0.7%+9.4
Q3 FY2024Sep 30, 2024-34.1%+8.9
Q2 FY2024Jun 30, 2024-47.7%−18.5
Q1 FY2024Mar 31, 2024-36.5%−4.7
Q4 FY2023Dec 31, 2023-10.1%−1.2
Q3 FY2023Sep 30, 2023-43.0%−6.3
Q2 FY2023Jun 30, 2023-29.2%+28.3
Q1 FY2023Mar 31, 2023-31.9%−0.8
Q4 FY2022Dec 31, 2022-8.9%+10.9
Q3 FY2022Sep 30, 2022-36.7%−7.0
Q2 FY2022Jun 30, 2022-57.5%−32.9
Q1 FY2022Mar 31, 2022-31.1%−18.1
Q4 FY2021Dec 31, 2021-19.8%−30.4
Q3 FY2021Sep 30, 2021-29.7%−11.1
Q2 FY2021Jun 30, 2021-24.6%+0.9
Q1 FY2021Mar 31, 2021-13.0%+1.3
Q4 FY2020Dec 31, 202010.6%–
Q3 FY2020Sep 30, 2020-18.6%–
Q2 FY2020Jun 30, 2020-25.5%–
Q1 FY2020Mar 31, 2020-14.3%–

More Treace Medical Concepts figures

See a number that looks wrong?